BIOGEN INC. Payments for Restructuring
BIOGEN INC. (BIIB) reported Payments for Restructuring of $40.20 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2017-02-02
- BIOGEN INC. payments for restructuring for the quarter ending 2016-06-30 was $5.00M.
- BIOGEN INC. payments for restructuring for the quarter ending 2016-03-31 was $29.70M.
- BIOGEN INC. payments for restructuring for the quarter ending 2015-12-31 was $72.00M.
- BIOGEN INC. payments for restructuring for fiscal 2016 was $40.20M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2016-12-31 | $40.20M 10-K · filed 2017-02-02 | |||
| 2016-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $34.70M 10-Q · filed 2016-07-21 | $106.70M derived: sum of 3 quarters · filed 2016-07-21 | |
| 2016-03-31 | $29.70M 10-Q · filed 2016-04-21 | $101.70M derived: sum of 2 quarters · filed 2016-04-21 | ||
| 2015-12-31 | $72.00M 10-K · filed 2016-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |